• Ian Morrissey, Consultant, Antimicrobial Focus Ltd. (UK)
  • Rebecca Li, CEO, Vivli (USA)
  • Patricia Bradford, Consultant, Antimicrobial Development Specialists LLC (USA)


  • Fernanda Lessa, Chief of International Infection Control, Centers for Disease Control and Prevention (USA)

This webinar will show the value of susceptibility surveillance data in defining the need for new antibacterials, designing target product profiles and planning clinical trials. The importance of openly sharing this data will be discussed. It will also feature more information on the 2024 Vivli AMR Surveillance Data Challenge which is co-funded by GARDP. Expressions of interest must be received by 28 July 2024.

Presentation 1: Antimicrobial resistance surveillance and new drug development (Ian Morrissey)

Presentation 2: The Vivli AMR Register – a mechanism for sharing and re-use for industry surveillance (Rebecca Li)

Presentation 3: The Vivli AMR Surveillance Data Challenge (Patricia Bradford)

This live webinar including an interactive Q&A session will be broadcast on 23 July 2024 at 17:00 – 18:30 CEST. Find your timezone here.

If you have questions or comments, please let us know: revive@gardp.org.